Pivot3 raises $45 mln

Pivot3 said Tuesday that it closed a $45 million equity and bank financing round. Argonaut Private Equity, a new investor in Pivot3, joined S3 Ventures, InterWest Partners, Mesirow Financial Private Equity and the Wilson Sonsini Goodrich & Rosati investment fund in providing additional equity. Austin-based Pivot3 develops hyper-converged infrastructure solutions.


Invuity pulls in $20 million in Wellington-led round

San Francisco-based Invuity Inc, a surgical photonics company, has closed $20 million in funding. Wellington Management LLP led the round with participation from other investors that included HealthCare Royalty Partners, Valence Life Sciences, InterWest Partners and Kleiner Perkins Caufield & Byers.


Obalon Therapeutics nabs $30 mln

San Diego-based Obalon Therapeutics, a developer of gastric balloon technology for weight loss therapy, has received $20 million in Series D funding and a $10 million loan from Square 1 Bank. The Series D investors included Axon Ventures, Mirae Asset Venture Investment, Striker Asia Opportunities Fund, Domain Associates, InterWest Partners and Okapi Venture Capital.


Welltok scores $37 mln Series D

Denver-based health optimization firm Welltok has closed its Series D funding round at $37 million. Bessemer Venture Partners led the round with participation from other investors that included Hearst Health Ventures, Catholic Health Initiatives, Emergence Capital Partners, InterWest Partners, New Enterprise Associates and Qualcomm Ventures.


InVisage Technologies snaps up $32.5 mln

Menlo Park, Calif.-based camera platform InVisage Technologies has received $32.5 million in funding. The investors in this round included China Oceanwide USA Holdings, GGV Capital, Nokia Growth Partners, InterWest Partners, Intel Capital and RockPort Capital.

PMV Pharmaceuticals grabs $30 mln

PMV Pharmaceuticals, which develops p53 targeted small molecule drugs to treat cancer, has raised $30 million in Series A financing. OrbiMed led the round with participation from Osage University Partners and supported by founding investor InterWest Partners. In addition to the funding, Dr. Peter Thompson of OrbiMed has been appointed to PMV’s board of directors.


Stellar Loyalty inks $5 mln Series A

Stellar Loyalty has closed $5 million in Series A funding. InterWest Partners led the round. Based in in Foster City, Calif. and Manila, Stellar Loyalty is a provider of cloud-based big data customer loyalty solutions.


Appboy grabs $15 mln Series B

Appboy said Thursday that it has secured $15 million in Series B funding. InterWest Partners led the round with participation from previous backers Icon Venture Partners, Blumberg Capital, T5 Capital and IDG Ventures. In addition to the funding, Doug Pepper, general partner at InterWest, has been appointed to Appboy’s board of directors. Based in New York City, Appboy is a provider of marketing automation for apps.


S3 Ventures led $12 mln round for Pivot3

Pivot3 has raised $12 million in funding round. S3 Ventures led the round with participation from return backers InterWest Partners and Mesirow Financial. Also, the firm has hired Mike Dansby as vice president and chief financial officer. Based in Austin, Texas, Pivot3 is a provider of data storage solutions.


VC-backed Tapjoy acquires 5Rocks

Mobile app tech firm Tapjoy has bought 5Rocks. No financial terms were disclosed. 5Rocks is a Korean provider of predictive analytics and marketing automation solutions. Tapjoy is backed by J.P. Morgan Asset Management, Rho Ventures, North Bridge Venture Partners, InterWest Partners and D.E. Shaw Ventures.


Cidara Therapeutics snags $32 mln Series A

Biopharmaceutical firm Cidara Therapeutics said Monday that it has secured $32 million in Series A funding. 5AM Ventures, Aisling Capital, Frazier Healthcare and InterWest Partners were the lead investors. In addition to the financing, the firm has hired Dr. Jeffrey Stein as president and CEO. It has also named Dr. Kevin Judice and Dr. H. Shaw Warren as chief operating officer and chief scientific officer respectively. Warren will also join Cidara’s scientific advisory board.  And, Dr. Ken Bartizal has been added as chief development officer while Dr. Dirk Thye has joined Cidara as chief medical officer.


Teva agrees to buy VC-backed Labrys for up to $825 mln

sraeli pharmaceutical company Teva Pharmaceutical Industries has agreed to acquire Labrys Biologics for $200 million in upfront payment in cash as well as up to $625 million in payments based on achievement of certain pre-launch milestones. Based in San Mateo, Calif., Labrys is a biotech firm focused on treating migraine. It was backed by venBio, Canaan Partners, InterWest Partners and Sofinnova Ventures.


The RealReal nets $20.3 mln

According to a Form D SEC filing, The RealReal has raised $20.3 million in a targeted $31 million round. Based in San Francisco, The RealReal is a luxury resale site whose previous backers include InterWest Partners, Canaan Partners, e.ventures, Greycroft Partners, Novel TMT Ventures, Suzy Welch and Panarea Capital.

VC-backed PMV Pharmaceuticals adds to board of directors

PMV Pharmaceuticals, which is backed by InterWest Partners, has appointed Steven Holtzman to its board of directors. Currently, Holtzman is the executive vice president of corporate development for Biogen Idec. PMV Pharmaceuticals is focused on developing first-in-class p53 and p53 pathway modulators that treat cancer and infectious disease.

Indi raises $47.25 mln

Molecular diagnostics company Indi has raised $30.25 million in a Series B and $17 million in non-dilutive debt financing provided by Life Sciences Alternative Funding. The round was led by Baird Capital and joined by Indi’s existing investors, InterWest Partners and the Wellcome Trust.

Integrated Diagnostics racks up $47.25 mln

Integrated Diagnostics said Tuesday that it has secured $30.25 million in Series B funding and $17 million in debt financing from Life Sciences Alternative Funding for a total tally of $47.25 million. Baird Capital led the Series B round with participation from return backers InterWest Partners and the Wellcome Trust. Based in Seattle, Integrated Diagnostics is a molecular diagnostics firm pioneering the use of blood-based proteomic tests.


Doximity raises $54 mln from DFJ, T Rowe Price, others

Doximity said it closing a $54 million round of Series C funding co-led by Draper Fisher Jurvetson and T. Rowe Price Associates, Inc. Morgan Stanley Investment Management also participated in the round as a new investor. Existing investors Emergence Capital Partners, Morgenthaler Ventures and InterWest Partners also joined the financing. Doximity, an online network for doctors, has more than tripled its user base since its last funding in September 2012 and has one in three U.S. doctors as members, the company said.

InVisage picks up $18 mln and expands team with new hires

InVisage Technologies has received $18 million in funding. Investors included GGV Capital, Nokia Growth Partners, RockPort Capital, InterWest Partners, Intel Capital and OnPoint Technologies. Also, InVisage has hired Ephraim Kwok as chief financial officer and Emanuele Mandelli as vice president of engineering. Based in Menlo Park, Calif., InVisage is a fabless semiconductor firm.

PE HUB Community

Join the 12514 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget